FindTrial
Sign In

Angiotensin converting enzyme inhibitor

DRUG6 trials

Sponsors

Vanderbilt University Medical Center, University of Wisconsin, Madison, UMC Utrecht, Medical Practice Prof D. Ivanov, Ottawa Heart Institute Research Corporation

Conditions

COVID-19Cardiovascular DiseaseCardiovascular DiseasesChronic Kidney DiseaseCommunity-acquired Pneumonia, Influenza, COVID-19Congenital Heart DiseaseHypertensionOxidative Stress

Phase 2

Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease
CompletedNCT00874432
University of Wisconsin, MadisonCardiovascular Disease, Chronic Kidney Disease
Start: 2009-01-31End: 2011-12-31Updated: 2020-10-27
The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients
CompletedNCT05232370
Unidad de Investigacion Medica en Enfermedades RenalesOxidative Stress
Start: 2022-01-01End: 2022-01-06Updated: 2022-02-09

Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RecruitingNCT02735707
UMC UtrechtCommunity-acquired Pneumonia, Influenza, COVID-19
Start: 2016-04-11End: 2028-02-29Target: 20000Updated: 2024-07-12
The COVID-RASi Trial (COVID-19)
CompletedNCT04591210
Ottawa Heart Institute Research CorporationCardiovascular Diseases, COVID-19
Start: 2021-01-27End: 2024-12-30Updated: 2026-01-28

Unknown Phase

Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children
CompletedNCT00848250
Vanderbilt University Medical CenterCongenital Heart Disease
Start: 2008-09-30End: 2010-07-31Updated: 2017-07-26
ARB, ACEi, DRi Effects on COVID-19 Course Disease
CompletedNCT04364984
Medical Practice Prof D. IvanovCOVID-19, Hypertension
Start: 2020-04-01End: 2021-08-01Updated: 2023-03-21

Related Papers

Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Thorax2025-05-139 citations
Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia
Intensive Care Medicine2025-04-0132 citations
A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial.
2023-12-068 citations
Simvastatin in Critically Ill Patients with Covid-19
New England Journal of Medicine2023-10-2559 citations
Intravenous Vitamin C for Patients Hospitalized With COVID-19
JAMA2023-10-2545 citations
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
JAMA2023-04-1166 citations
The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors
The Journal of Infectious Diseases2023-03-274 citations
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
JAMA2023-03-2192 citations
The Impact of COVID-19 Research on the Development of Scalable Frameworks for Efficient Clinical Trials in Cardiovascular Medicine
Canadian Journal of Cardiology2023-03-153 citations
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.
2022-12-0128 citations
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.
2022-09-2211 citations
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
JAMA2022-03-22144 citations
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial
BMJ2022-01-0779 citations
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID‐19: Insights from the HOPE COVID‐19 Registry
International Journal of Clinical Practice2022-01-015 citations
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
JAMA2021-10-05208 citations
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Bristol Research (University of Bristol)2021-08-26586 citations
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
New England Journal of Medicine2021-08-041046 citations
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine2021-08-04947 citations
Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19.
2021-07-197 citations
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
BMJ Open2021-06-0127 citations

5 more papers not shown